Loading insider details...
Beta
Latest Form 4 (Oct 16, 2026): Sale of 3,000 GILD shares, $468.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | GILEAD SCIENCES, INC. (GILD) | Sale | 3,000 | $468.7K |
| Sep 16, 2026 | GILEAD SCIENCES, INC. (GILD) | Sale | 1,600 | $229.9K |
| Sep 11, 2026 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 2,797 | n/a |
| Aug 18, 2026 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 23,110 | $1.54M |
| Jul 16, 2026 | GILEAD SCIENCES, INC. (GILD) | Sale | 3,000 | $389.8K |
| Jun 16, 2026 | GILEAD SCIENCES, INC. (GILD) | Sale | 1,480 | $182.7K |
| Jun 11, 2026 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 2,796 | n/a |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 2,567 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 3,318 | n/a |
| May 18, 2026 | GILEAD SCIENCES, INC. (GILD) | Exercise/Conversion | 25,000 | $1.67M |